This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
EAS Covid 19 Webinar

Lipids and atherosclerosis in the COVID era

Since the emergence of the pandemic due to COVID-19, we have come to learn that it is not a simple viral pneumonia. The virus also binds to endothelial cells, myocardial cells, renal tubular cells among others and triggers a multisystem inflammation, cytokine storm and thromboembolism. This can lead to cardiovascular complications such as acute coronary syndromes, myocarditis and arrythmia and multiorgan failure. The medications we use to treat the disease have drug interactions and cardiovascular consequences. With increased risk of inflammation and thrombosis, patients with atherosclerotic vascular disease and hyperlipidemia are a vulnerable group requiring frequent and continued medical attention. The COVID-19 pandemic has significantly affected the heart healthy lifestyle and access to healthcare of our patients.

In this webinar, we discuss the consequences of COVID-19 infection for atherosclerotic vascular disease, lipids and lipid lowering medications.

View the webinar + Q&A on-demand for free here >>




S. Lale Tokgozoglu, MD, FACC, FESC. Professor of Cardiology,
Hacettepe University, President of EAS, Ankara, Turkey


Read more about Prof Tokgozoglu


Expert Speakers

Giuseppina Caligiuri, MD, PhD, Research Director,
Inserm, Paris, France

Read more about Prof Caligiuri's expertise


Alberto Corsini,  PharmD, PhD, Professor of Pharmacology,
University of Milan, Italy

Read more about Prof Corsini's expertise


Handrean Soran, MBChB, MSc, MD, FRCP, Consultant Physician, Endocrinologist,
University of Manchester, United Kingdom 

Read more about Dr Soran's expertise




  • Endothelium and inflammation – interplay with COVID, Professor Caligiuri
  • What we learned from previous ARDSs and how should we approach lipid lowering therapy in the COVID19 era? Professor Soran
  • Drug-drug interactions for lipid-lowering therapy, Professor Corsini


Live Q&A

ASK your questions to our experts, to apply your learning in your own practice.
uestions will be answered live during the webinar.

EAS Education

Find out more about EAS educational activities, including our EAS 2020 Virtual Congress.

Membership Software Powered by YourMembership  ::  Legal